Preparation of Epidermal Cells. The donor was killed by cervical dislocation, the hair on the abdomen and thorax was removed with clippers, and the mouse was dipped in 70% aqueous alcohol. Large pieces of skin were cut from the abdomen and thorax and minced into small fragments which were then incubated with gentle agitation by a magnetic stirrer for 30 rain at room temperature in 50 ml of 0.25% trypsin (made in Ca ++-and Mg++-free Hanks' balanced salt solution, HBSS, pH adjusted to 6.8-6.9). The supernate was decanted, and the remaining tissue was incubated three more times with fresh trypsin solution. The cells from the third and fourth decanted cell suspensions were concentrated by centrifugation at 220 g for 10 rain, and then resuspended in HBSS containing 20% fetal calf sernm (FCS). The suspension was filtered through a 20-ml syringe containing Leukopak fibers lightly dry-packed into a layer 4-to 5-ram thick. Live cells were counted, resuspended in HBSS-FCS, incubated for 90 rain at 37°C, and then used in the cytotoxic test.
CML Assay. The CML assay was performed as described elsewhere (25) . We used concanavalin A (ConA)-or lipopolysaccharide (LPS)-stimulated blasts as target cells. Since we found no difference in the degree of lysis of these two targets, we pooled the data from the corresponding experiments.
Results

Genetic Homogeneity of Strains Used.
For the types of experiments described below, it is imperative to establish beforehand that any rejections observed are not caused by residual heterozygosity of the mouse lines used. For this reason, we randomly selected 10 sex-matched mice of each of the critical 7 strains (A.TL, A.TH, B10.AQR, 6R, 7R, 9R, and B10.HT1 ~) and exchanged skin grafts between the individual animals in the manner of the reciprocal circle (26) . None of the grafts was rejected during the observation period of 100 days, indicating that no histocompatibility loci were segregating in the seven lines.
Background Identity. Another important criterion that has to be satisfied before a genetic study of histocompatibility requirements can begin is the background identity of congenic lines used. To determine whether the congenic lines do indeed differ only in the H-2 complex, as expected, the following F1 hybrid tests were performed: A -* (A. 
TL x B10.A)FI, A --* (A.TH × B10.A)F1, B10.BR--, (7R × C3H)F1, B10.BR-, (9R × C3H)F~, B10.BR--* (B10.HTT × C3H)F~, B10.A--, (6R × A)F~, and B10.A--, (B10.AQR × A)F~. In each of these seven strain combinations, one parent of the F~ hybrid provided the H-2 haplo-
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y2 1441 type and the other the rest of the genome of the donor strain. Therefore, if, indeed, the seven tested congenic lines were to have the genome of either the A strain (lines A.TH and A.TL) or the B10 strain (the remaining 5 lines), grafts transplanted in these combinations should have survived permanently. 7-12 sex-matched mice in each of the seven strain combinations were grafted with tail skin. In six of the seven combinations no rejections occurred during the 100-day observation period; in one combination [B10.A -* (B10.AQR x A)F1], five grafl~ survived for over 100 days, whereas two grafts were rejected, one 73 and the other 85 days after transplantation. We conclude from these experiments that six of the seven tested congenic lines do not differ in any minor H loci from their inbred partners; the seventh line (B10.AQR) appears weakly histeincompatible with its inbred partner. The weak residual histoincompatibility of B10.AQR, however, did not interfere with the type of experiments described herein.
Mapping of the Strong 1-Region Histocompatibility Locus.
Once we established the genetic homogeneity and cengenicity of the critical mouse lines, we attempted to map within the I region the strong H locus which we described previously (9) . Summary of the mapping data is given in Table II. The first four  strain combinations listed in this table confirm the presence of the strong I- region-associated H locus in four additional H-2 haplotypes (t/, t2, yl, andy2). In pairs of congenic lines carrying these haplotypes and differing in central H-2 regions, all exchanged skin grafts were rejected within 3 wk after grafting. The remaining two strain combinations in Table II map the strong H locus in the 1.4 subregion. Since no strain combination differing only at the IA subregion is available, the mapping had to be indirect. It was based on comparing two strain combinations, one differing inIA + IB subregions and the other differing in the IB subregion only. In the former strain combination, all skin grafts were rapidly rejected (within 3 wk after transplantation); in the latter combination, two out of nine grafts survived for more than 80 days, while the remaining grafts were rejected but in a delayed and chronic fashion, indicating the presence of only a weak H barrier. Since in this strain combination the donor differs from the recipient also in the T region which is known to be associated with weak H loci (27), we consider it likely that the observed minor histoincompatibility is caused by the T region loci. We conclude, therefore, that the rapid rejection of skin allografts is associated with the IA subregion. Mapping of the Weak I-Region Histocompatibility Locus. Table HI lists eight donor-recipient combinations that are genetically compatible at K, D, and A regions but incompatible at C, S, and G regions; six of these combinations are also incompatible at the T region. In all eight combinations, skin-graft rejections were observed. Depending on the particular combination, the proportion of rejected gral~ varied from between 30 and 100%. Although some of the first-set grafts were rejected as early as 2 wk after tranplantation, the rejection of the majority of grafts was delayed for a month or longer. Frequently, the rejection process was protracted over a period of several weeks. Some grafts that were never rejected, nevertheless, underwent a "cosmetic crisis" characterized by a temporary loss of hair crop and scaliness. The crisis lasted from 1 to 2 wk, but then the grafts recovered and remained healthy for the remainder of the observation period. After rejection of first-set grafts, recipients were regrafted with skin from the same donor strain. Majority of the second-set grafts were rejected in an accelerated manner, although, again, some grafts survived for the entire observation period. This behavior of skin grafts is characteristic of weak histocompatibility barriers and thus indicates that the tested donor-recipient combinations differ at minor H loci. In six of the tested combinations, the rejections might have been caused by genetic differences at the T region which previously has been demonstrated to contain minor H loci (27) . In the two reciprocal 7R ~ 9R combinations, however, no difference at the T region was present, and yet the skin grafts were rejected. This result suggests that the portion of the H-2 complex to the right of IA and to the left olD also contains a minor H locus. To map this locus further, we graitod C3H.OL skin on (D2.GD x C3H)FI hybrids. In this combination, the donor differs from the recipient only in the IC subregion. The rejection of skin grafts in this strain combination indicates that it is the IC subregion that contains the minor H locus.
The Involvement of the I Region in CML. To test whether antigens coded for by the IA and IC subregions can also function as targets in the in vitro CML assay, we took some of the mice that rejected their skin grafts, restimulated their spleen cells in vitro with the donor cells, and then tested the effector cells against 51Cr-labeled target cells (Con A or LPS blasts derived from donor lymphocytes). Most combinations were tested in three to four independent experiments with at least three replicas per each combination and with three effector.target cell ratios (50:1, 25:1, and 12:1). A typical experiment is shown in Fig. 1 , and the data are summarized in Table IV . In all combinations differing at the IA subregion, strong lympholysis was observed (see also reference 10); in all combinations differing in IB, IC, S, G, and T subregions, much weaker lympholysis was obtained, indicating that the strong killing was directed against antigens controlled by the IA subregion. Particularly informative in this respect are the combinations (B10.Q x B10.D2)F1 anti-B10.AQR and (4R x B10.D2)F1 anti-B10.A. The weak lympholysis observed in these two combinations was most likely directed against IC antigens (former combination) or T antigens (latter combination).
In all combinations differing at the IC subregion, a weak but significant killing was observed. In combinations 7R ~ B10.HTT and 9R ~ B10.HTT, this killing could have been caused by antigens ceded for by S or G regions; but in the (D2.GD x C3H)F1 anti-C3H.OL combination, the killing must have been directed against antigens of the IC subregion. We conclude, therefore, that ICsubregion antigens can function as targets in the CML assay.
To determine the nature of the killer cells responsible for the CML in these combinations, we exposed the effector cell suspension, before mixing it with target cells, to an AKR anti-C3H (anti-Thy-l.1) serum (dilution 1:5), incubated the cells for 30 rain at room temperature, washed the suspension three times, incubated the cells with a 3:1 mixture of normal guinea pig and rabbit sera (as a source of complement), then incubated the cells for additional 30 rain at room temperature, washed, and then resnspended them to the desired concentration. The treatment almost completely abolished the lympholytic capacity of the effector cell suspension (Fig. 2) , indicating that the killer cells in this assay were T lymphocytes.
Production of la ,Antibodies in Skin-Grafted Mice. Some of the animals that received second-or third-set skin grafts in strain combinations listed in Table HI were bled once a week for 8 wk and their sera individually tested in the cytotoxic test against spleen cells of the proper 1-1-2 haplotype. In two strain combinations, 7R anti-B10.HTT and (A.TH x 4R)F~ anti-A.TL, antibodies were found in the recipients' sera (Table V) . The antibodies appeared early after the second grafting (within 2 wk) and often persisted for at least 8 wk. The positive antisera were pooled, and the pools were then used for additional tests. Both antisera killed only about 60% of unfractionated spleen cells, almost 100 percent of B lymphocytes, but almost no T lymphocytes (Fig. 2) , suggesting that the antibodies they contained were directed against la antigens. This suggestion was confirmed by testing the pooled antisera against a panel of 1-1-2 congenic lines andH-2 recombinants (Table VI) . The reactivity pattern of these antisora can be best explained by assuming that they are directed against antigens coded for by the IC subregion. 
Reactivity in the Cytotoxic Test of Sera from Mice Transplanted with Skin Grafts
Mouse no.
Reciprocal of titre* at days after transplantation (Table HI) . Thus the position of the H-2A locus in the IA subregion is relatively well established. The mapping of the H-2C locus in the IC subregion is based on the rejection of C3H.OL grafts placed on (D2.GD x C3H)F~ hybrids (donor-recipient difference at theIC subregion only). However, this mapping, too, is supported by rejections in additional combinations in which the difference is in theIC, S, and G regions. In previous tests (28), we found no evidence for the S or G regions causing graft rejections and we assume, therefore, that in these IC + S + G-disparate combinations, the rejections are caused byIC-region antigens. Rejections of skin grai~ in IC + S + G-disparate combinations was also observed by Stimpfling 2 and McKenzie and Henning (29) .
The H-2A locus causes skin graft rejection within 3 wk (this communication) and heart-muscle rejection within 5 wk after transplantation. locus is apparently also responsible for rapid rejection of I-region-imcompatible lymphomas (30) and mammary adenocarcinomas (30 and J. Klein, unpublished data). Therefore, with regard to its strength, the locus is comparable to the H-2K or H-2D loci residing in the K and D regions, respectively. Testing of different H-2 haplotypes indicated that at least four alleles exist at this locus, and there is every reason to believe that the locus is as polymorphic as the H-2K and H-2D loci. Antigens coded for by the H-2A locus serve as the targets in the in vitro CML assay when the assay is performed under optimal culture conditions (11, 12) or when spleens from in vivo presensitized animals are used as source of effector cells (10 and this communication). The mechanism of the IAregion killing in the CML assay is still under study, but the data available thus far indicate that the killing is mediated by T cells (12) and that it does not require K-or D-region compatibility (J. Klein and C. Chiang, unpublished data). This latter property distinguishes the H-2A antigens from all minor H antigens which have been shown by Bevan (31) to serve as targets in CML only when the target cell shares with the stimulating cell the same allele at either the H-2K or the H-2D locus. In this respect the H-2A locus is an equal partner to the H-2K andH-2D loci. In fact, the only major characteristic in which the H-2A locus differs from the H-2K and H-2D loci is its failure to mediate syngeneic lymphocytotoxicity against virus-infected or haptenated cells. Blanden et al. (32) reported that effector cells generated against syngeneic cells infected with the lymphocytic choriomeningitis or vaccinia virus will lyse virus-infected target cells in vitro, provided that the responding (and the stimulating) cell shares with the target cell either the K or the D region; sharing of I region is not sufficient to mediate the lympholysis. Similarly, Shearer et al. (33) and Forman (34) observed that sharing of K or D regions is necessary for lympholysis of trinitrophenyl (TNP)-modified target cells by effector cells generated against TNP-modified stimulating cells. Here again, sharing of the I region does not suffice for the lympholysis to occur. However, one should bear in mind that reproducible demonstration of allogeneic CML across the I region requires optimization of the culture conditions and it is, therefore, still possible that similar optimization will also be required for the demonstration of syngeneic CML against neoantigens. At the time of this writing the problem of syngeneic I-region CML certainly must be considered as open to further investigation. The Ho2C locus is extremely weak and must, therefore, be classified as minor. Some first-set skin grat~s transplanted across H-2C barriers remained healthy for at least 100 days, while others were rejected within this period of time. The rejection times range from between 14 and more than 80 days after grafting. The rejection process across H-2C barriers is protracted and often lasts for several weeks. Most second-set skin grat~s are rejected in an accelerated manner. Whether the locus can cause rejection of grai~ from tissues other than skin is not known.
By using in vivo sensitized mice as a source of effector cells, and by restimulating the effector cells in vitro, we were able to establish that the antigens coded for by the H-2C locus can also function as targets in the in vitro CML assay. Nabholz et al. (12) observed lympholysis by cells primed in vitro against antigens controlled by the right~hand portion of the central H-2 segment. They suggested that the killing they observed was directed against antigens coded for by the IC subregion, but, in fact, the strain combinations that they tested also differed in the S, G, and T regions, and the authors did not exclude the possibility that the observed lympholysis might have been caused by these three regions. The observation of positive CML in the strain combination (D2.GD × C3H)F1 anti-C3H.OL (Table IV) is thus the first unequivocal demonstration that IC antigens serve as targets in the CML assay. The critical question now is whether the IC lympholysis required compatibility at the K or the D region, in the same way as all minor H loci do (31) . Experiments to answer this question are in progress. If it, indeed, turns out that IC killing were not to occur in K-D incompatible combinations, then the H-2C locus will have to be considered as another member of the growing family of minor H loci. Some 40 such loci have been identified in the mouse (13) , and Bailey (35) has predicted that several hundreds of these loci may actually exist. Since minor H loci are distributed all over the mouse genome, it would not be surprising to find some of them within the H-2 complex. On the other hand, if it were to turn out that the IC killing does not require K-D compatibility, as is the case of the H-2A locus, one will have to postulate that the I-regionH loci differ from minor H loci in some special intrinsic properties.
The relationship of the H-2A and H-2C loci to the Ia loci is not clear. Three observations can be interpreted as indicating that the Ia products themselves may function as transplantation antigens. The first observation is that skin (9), heart, 3 and tumor (J. Klein, unpublished data) graft rejection across the Iregion barrier is accompanied by the production of Ia antibodies. This production is particularly evident after grafting across/A-subregion differences. We found Ia antibodies in all/A-disparate combinations tested, usually after firstset gaining and around the time of the grafts' rejection. In/C-disparate graft~ ings, Ia antibodies are found in only some combinations and usually can be detected only after exposure of the animal to second-or third-set grafts. However, we have not excluded the possibility that the Ia antibodies are formed against Ia antigens on passenger leukocytes present in the skin (36) , and that they have nothing to do with the transplantation antigens against which the allograft reaction is directed. The second observation is that Ia antigens con- The third observation is that loci coding for transplantation antigens map in the same I subregions as the loci coding for la antigens. However, this last evidence is not very convincing since many strain combinations still have not been tested, and it is quite possible that thorough analysis designed specifically to look for minor H loci within the H-2 complex will uncover additional such loci. On the other hand, it would not be surprising if the la antigens were to turn out to be also transplantation antigens. After all, they are expressed on the cell surface, and they are part of a histocompatibility complex.
Summary
Skin grafts were reciprocally exchanged in pairs of congenic lines identical in all genes except those located in the central portion of the H-2 complex. Seven such lines were tested: 6R, B10.AQR, A.TL, A.TH, 7R, 9R, and B10.HTT. In all donor-recipient combinations at least some grafts were rejected. In combinations differing at the IA subregion (and other central H-2 regions or subregions), all first-set grafts were rejected within 3 wk after transplantation, and all secondset grafts were rejected within 10 days. In combinations differing at the IC subregion (and other central regions, but not at the IA subregion) between 60 and 100% of first-set grafts were rejected, but some grafts survived for over 100 days. Most of the second-set grafts were rejected within i mo after grafting. This behavior of skin grafts indicated the presence of two histocompatibility loci in the I region, a strong one and a weak one. This conclusion was confirmed by genetic mapping which placed the strong locus in the IA subregion and the weak locus in the IC subregion. We designate the former locus H-2A and the latter H-2C. The same strain combinations used for the skin grafting were also used for determination of the capacity ofl-region antigens to function as targets in the in vitro cell-mediated lymphocytotoxicity (CML) assay. Spleen cells from mice presensitized in vivo by skin grafting were restimulated in vitro and tested against 51Cr-labeled concanavalin A or lipopolysaccharide blasts. The testing revealed the presence in the I region of two loci coding for CML-target antigens. The two loci comapped with the H-2A and H-2C loci and were most likely identical to them. As in the skin grafting test, in the CML test, the H-2A antigens evoked stronger response than the H-2C antigens. Rejection of skin grafts across the H-2A and H-2C loci was accompanied by the production of la antibodies. Direct cytotoxic and absorption tests with Ia antibodies directed against antigens coded for by the IC subregion revealed the presence of laC antigens on epidermal cells. We suggest that the products of la loci might function as transplantation antigens.
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